| n | Incidence rate (per 10,000 person-years) | Model 1 | Model 2 |
---|---|---|---|---|
Components | ||||
 High WC | 462 | 27.95 | 2.63 (1.39–4.97)* | 1.92 (0.93–3.97) |
 High BP | 456 | 18.74 | 1.58 (0.77–3.22) | 1.37 (0.66–2.81) |
 Low HDL-C | 1295 | 15.68 | 1.20 (0.66–2.18) | 1.11 (0.61–2.01) |
 High TGs | 1030 | 18.70 | 1.82 (1.00–3.34)* | 1.68 (0.92–3.09) |
 High FPG | 199 | 17.19 | 1.51 (0.53–4.26) | 1.49 (0.53–4.22) |
Dual combinations | ||||
 High TGs and high WC | 285 | 34.79 | 3.56 (1.78–7.10)* | 2.70 (1.27–5.77)* |
 High FPG and high WC | 39 | 21.53 | 1.70 (0.23–12.42) | 1.37 (0.19–10.09) |
 Low HDL-C and high WC | 269 | 27.12 | 2.42 (1.12–5.23)* | 1.66 (0.71–3.85) |
 High BP and high WC | 126 | 43.37 | 3.84 (1.62–9.13)* | 2.52 (1.00–6.33)* |
 High TGs and high FPG | 87 | 19.58 | 1.58 (0.38–6.61) | 1.50 (0.36–6.28) |
 High TGs and low HDL-C | 621 | 21.14 | 1.86 (0.99–3.49)* | 1.68 (0.89–3.17) |
 High TGs and high BP | 215 | 31.38 | 2.83 (1.29–6.16)* | 2.27 (1.02–5.05)* |
 High FPG and low HDL-C | 92 | 27.54 | 2.41 (0.74–7.83) | 2.08 (0.64–6.80) |
 High FPG and high BP | 36 | 42.33 | 3.79 (0.91–15.76) | 3.35 (0.80-14.08) |
 Low HDL-C and high BP | 190 | 31.47 | 2.67 (1.18–6.01)* | 2.15 (0.94–4.90) |
 Metabolic syndrome | 338 | 33.78 | 3.55 (1.84–6.87)* | 2.82 (1.41–5.64)* |